You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hydroxysteroid 11-β dehydrogenase 1 (HSD11B1)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes in Obese, Obesity, Type2Diabetes Trial in San Diego (SPI-62, Cortisone-d8)

Completed
  • Type 2 Diabetes Mellitus in Obese
  • +2 more
  • Chula Vista, California
    ProSciento
Jan 26, 2023

Idiopathic Intracranial Hypertension Trial in Birmingham (AZD4017, Placebo)

Completed
Has Results
  • Idiopathic Intracranial Hypertension
  • Birmingham, West Midlands, United Kingdom
    University Hospital Birmingham (Queen Elizabeth Hospital)
Sep 28, 2021

Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)

Completed
  • Iatrogenic Cushing's Disease
  • AZD4017 and prednisolone
  • Placebo Oral Tablet and prednisolone
  • Oxford, United Kingdom
    University of Oxford
May 12, 2021

Cortisol Metabolism in Familial Partial Lipodystrophy Type 2

Recruiting
  • Familial Partial Lipodystrophy Type 2
  • Biopsy
  • Lille, France
    Hop Claude Huriez
Jun 20, 2022

Disorder of Sex Development, 46,XY Trial in Rotterdam (Testosterone gel, Placebo)

Not yet recruiting
  • Disorder of Sex Development, 46,XY
  • Testosterone gel
  • Placebo
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Apr 2, 2021

Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)

Not yet recruiting
  • Crohn's Disease
  • Stockholm, Sweden
    Research Site
Sep 22, 2023

Hypoparathyroidism Trial in Jerusalem (EBP05, Forteo 20 mg, EBP11)

Recruiting
  • Hypoparathyroidism
  • Jerusalem, Israel
    Clinical Research Center Hadassah Ein Kerem Medical Center
Jul 27, 2023

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

    Recruiting
    • ER+ Breast Cancer
    • 4FMFES-PET
    • Sherbrooke, Quebec, Canada
      Université deSherbrooke
    Jul 18, 2022

    Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita Trial in London (IMP Application KM-001, Physical Examination,

    Recruiting
    • Punctate Palmoplantar Keratoderma Type 1
    • Pachyonychia Congenita
    • IMP Application KM-001
    • +14 more
    • London, Whitechapel Rd, United Kingdom
      Royal London Hospital-Clinical Research Facility-11D (11th Floor
    Jul 23, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los

    Terminated
    • Biochemically Recurrent Prostate Carcinoma
    • +5 more
    • Computed Tomography
    • +2 more
    • Los Angeles, California
      University of California at Los Angeles / Jonsson Comprehensive
    Oct 19, 2022

    Parkinson Disease Trial in Nashville ([11C]-PIB)

    Recruiting
    • Parkinson Disease
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Apr 28, 2022

    MDD Trial (SAGE-217)

    Not yet recruiting
    • Major Depressive Disorder
    • (no location specified)
    Dec 9, 2022

    Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

    Not yet recruiting
    • Hematologic Malignancy
    • +21 more
    • (no location specified)
    Feb 9, 2023

    Pharmacokinetics, Bioavailability Trial in Nottingham (Sorafenib - Period 1, XS005 Sorafenib Capsule A - Period 1, XS005

    Completed
    • Pharmacokinetics
    • Bioavailability
    • Sorafenib - Period 1
    • +8 more
    • Nottingham, United Kingdom
      Quotient Sciences
    Jul 20, 2023

    DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

    Recruiting
    • Diffuse Large B-Cell Lymphoma
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 12, 2022

    Adrenal and Other Endocrine Tumors in Patients With Sudden Death

    Recruiting
    • Primary Aldosteronism
    • +3 more
    • Adrenal aldosterone synthase (CYP11B2) staining
    • +2 more
    • Helsinki, Finland
      Endocrinology, Helsinki University Hospital and University of He
    Jul 8, 2022

    Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

    Active, not recruiting
    • Malignant Supratentorial Neoplasm
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2021

    MDD Trial in London (MIJ821)

    Not yet recruiting
    • Major Depressive Disorder
    • London, United Kingdom
      Parexel Early Phase Clinical Unit (LONDON)
    Dec 18, 2022

    Advanced or Metastatic Solid Tumors Trial (DCBY02)

    Not yet recruiting
    • Advanced or Metastatic Solid Tumors
    • (no location specified)
    Aug 9, 2022

    MDD, Treatment Resistant Depression Trial in Toronto ([11C]SL25.1188 PET radiotracer)

    Recruiting
    • Major Depressive Disorder
    • Treatment Resistant Depression
    • [11C]SL25.1188 PET radiotracer
    • Toronto, Ontario, Canada
      CAMH
    Mar 31, 2022

    HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

    Not yet recruiting
    • HIV-1-infection
    • VRC07-523LS
    • +7 more
    • Pathum Wan, Bangkok, Thailand
    • +1 more
    Mar 8, 2023

    Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan

    Withdrawn
    • Metastatic Ewing Sarcoma
    • Recurrent Ewing Sarcoma
    • Fine-Needle Aspiration
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Jul 19, 2022